Privia Health Group (NASDAQ:PRVA) Shares Gap Down – Time to Sell?

Privia Health Group, Inc. (NASDAQ:PRVA) gapped down before the market opened on Thursday . The stock had previously closed at $23.96, but opened at $20.90. Privia Health Group shares last traded at $20.9930, with a volume of 401,384 shares changing hands.

Privia Health Group News Roundup

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia reported second-quarter revenue of $632.6 million, up 21.4% year over year and above the approximately $597.3 million consensus. Net income rose to $9.0 million from $2.7 million, while adjusted EBITDA increased 29.1% to $37.4 million. Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
• Positive Sentiment: Management raised or improved its full-year 2026 expectations across key operating metrics, including attributed lives, practice collections, GAAP revenue, care margin, platform contribution and adjusted EBITDA. Revenue is expected toward the high end of the $2.35 billion-$2.45 billion range, with adjusted EBITDA of $145 million-$155 million. Privia Health Raises 2026 Outlook
• Positive Sentiment: Underlying growth indicators remained strong: implemented providers rose 10.1% to 5,644, value-based-care attributed lives increased 19.2% to 1.647 million, and the adjusted EBITDA margin expanded to 28.3% from 25.2%. Privia Health Q2 2026 Earnings Presentation
• Neutral Sentiment: Zacks upgraded PRVA from “strong sell” to “hold,” signaling reduced downside expectations but not a bullish recommendation. Zacks
• Negative Sentiment: GAAP EPS was $0.07, narrowly below Zacks’ $0.08 estimate. Reported profitability also included $19.4 million of non-cash stock-based compensation, while operating cash flow was negative $48.4 million in the first half, factors that may temper enthusiasm over earnings quality. Privia Health Misses Q2 Earnings Estimates

Analysts Set New Price Targets

Several research firms have commented on PRVA. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday. Citigroup reaffirmed a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Barclays reduced their target price on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Finally, Canaccord Genuity Group set a $32.00 price target on shares of Privia Health Group in a research note on Friday. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.00.

Privia Health Group Trading Up 2.0%

The stock’s fifty day moving average is $24.63 and its 200 day moving average is $23.35. The company has a market capitalization of $2.83 billion, a P/E ratio of 106.91, a price-to-earnings-growth ratio of 1.74 and a beta of 0.85.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 15,647 shares of Privia Health Group stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $22.64, for a total value of $354,248.08. Following the sale, the chief executive officer directly owned 434,357 shares in the company, valued at approximately $9,833,842.48. This trade represents a 3.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Matthew Shawn Morris sold 53,722 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $27.24, for a total value of $1,463,387.28. Following the transaction, the director directly owned 68,188 shares in the company, valued at $1,857,441.12. This trade represents a 44.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 452,357 shares of company stock worth $11,436,655. Company insiders own 5.70% of the company’s stock.

Institutional Trading of Privia Health Group

Several large investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada raised its stake in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after buying an additional 95,371 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Privia Health Group by 24.7% in the 1st quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after acquiring an additional 8,068 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Privia Health Group by 3.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after purchasing an additional 3,714 shares during the period. Intech Investment Management LLC lifted its stake in shares of Privia Health Group by 55.1% in the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after purchasing an additional 20,082 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in shares of Privia Health Group during the first quarter valued at approximately $154,000. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.